Raymond James & Associates’s iShares MSCI ACWI ex US ETF ACWX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$10.1M Buy
176,179
+5,091
+3% +$277K 0.01% 1230
2024
Q2
$9.09M Sell
171,088
-6,698
-4% -$357K 0.01% 1220
2024
Q1
$9.49M Sell
177,786
-10,241
-5% -$526K 0.01% 1187
2023
Q4
$9.6M Sell
188,027
-7,003
-4% -$337K 0.01% 1133
2023
Q3
$9.17M Buy
195,030
+107,839
+124% +$5.28M 0.01% 1084
2023
Q2
$4.29M Buy
87,191
+1,674
+2% +$82.4K ﹤0.01% 1589
2023
Q1
$4.17M Sell
85,517
-41
-0% -$1.98K ﹤0.01% 1589
2022
Q4
$3.89M Sell
85,558
-65,020
-43% -$2.85M ﹤0.01% 1577
2022
Q3
$6.03M Buy
150,578
+33,607
+29% +$1.5M 0.01% 1242
2022
Q2
$5.26M Sell
116,971
-4,716
-4% -$228K 0.01% 1375
2022
Q1
$6.36M Sell
121,687
-33,769
-22% -$1.8M 0.01% 1336
2021
Q4
$8.64M Sell
155,456
-7,744
-5% -$436K 0.01% 1190
2021
Q3
$9.04M Sell
163,200
-3,682
-2% -$210K 0.01% 1113
2021
Q2
$9.6M Sell
166,882
-14,192
-8% -$815K 0.01% 1095
2021
Q1
$9.99M Buy
181,074
+10,981
+6% +$607K 0.01% 1036
2020
Q4
$9.02M Sell
170,093
-37,407
-18% -$1.86M 0.01% 1014
2020
Q3
$9.54M Sell
207,500
-43,597
-17% -$2.01M 0.01% 882
2020
Q2
$10.9M Sell
251,097
-132,016
-34% -$5.4M 0.01% 787
2020
Q1
$14.4M Sell
383,113
-128,098
-25% -$5.76M 0.02% 577
2019
Q4
$25.1M Sell
511,211
-54,690
-10% -$2.61M 0.03% 490
2019
Q3
$26.1M Sell
565,901
-120,693
-18% -$5.52M 0.04% 444
2019
Q2
$32.1M Sell
686,594
-145,127
-17% -$6.74M 0.05% 380
2019
Q1
$38.5M Sell
831,721
-108,080
-12% -$4.87M 0.06% 312
2018
Q4
$39.4M Sell
939,801
-153,150
-14% -$6.75M 0.07% 262
2018
Q3
$52.1M Sell
1,092,951
-12,856
-1% -$611K 0.08% 226
2018
Q2
$52.2M Buy
1,105,807
+33,133
+3% +$1.64M 0.09% 214
2018
Q1
$53.3M Buy
1,072,674
+109,274
+11% +$5.56M 0.1% 203
2017
Q4
$48.1M Buy
963,400
+175,722
+22% +$8.66M 0.09% 209
2017
Q3
$38.1M Sell
787,678
-31,421
-4% -$1.48M 0.08% 245
2017
Q2
$37.3M Buy
819,099
+15,730
+2% +$710K 0.08% 243
2017
Q1
$35M Buy
803,369
+142,713
+22% +$6.05M 0.08% 245
2016
Q4
$26.6M Sell
660,656
-53,105
-7% -$2.15M 0.07% 285
2016
Q3
$29.6M Sell
713,761
-22,136
-3% -$901K 0.08% 243
2016
Q2
$28.7M Buy
735,897
+50,921
+7% +$2.02M 0.09% 239
2016
Q1
$27M Buy
684,976
+102,676
+18% +$3.84M 0.09% 234
2015
Q4
$23.1M Buy
582,300
+491,055
+538% +$20.1M 0.08% 264
2015
Q3
$3.56M Sell
91,245
-85,539
-48% -$3.6M 0.01% 918
2015
Q2
$7.81M Buy
176,784
+95,886
+119% +$4.46M 0.03% 610
2015
Q1
$3.62M Buy
80,898
+1,459
+2% +$64.1K 0.02% 900
2014
Q4
$3.42M Buy
79,439
+27,256
+52% +$1.21M 0.02% 872
2014
Q3
$2.37M Buy
52,183
+16
+0% +$759 0.01% 1019
2014
Q2
$2.5M Buy
52,167
+3,223
+7% +$154K 0.02% 966
2014
Q1
$2.28M Sell
48,944
-61,958
-56% -$2.82M 0.02% 959
2013
Q4
$5.18M Buy
110,902
+9,903
+10% +$454K 0.04% 522
2013
Q3
$4.53M Buy
100,999
+7,496
+8% +$324K 0.04% 513
2013
Q2
$3.81M Buy
+93,503
New +$4.04M 0.04% 532

Other funds holding ACWX

Raymond James & Associates's ACWX Position: Q3 2024 in Review

Raymond James & Associates increased its iShares MSCI ACWI ex US ETF (ACWX) stake by 3% in Q3 2024, buying an estimated $277K and bringing the position to 176,179 shares worth $10.1M. The position accounts for 0.01% of the portfolio, ranked #1230.

Raymond James & Associates first reported a position in ACWX in Q2 2013 and has held it in 46 quarters since. The position peaked at $53.3M in Q1 2018. 457 funds tracked by Wall St. Rank hold ACWX as of Q3 2024.

  • Raymond James & Associates held 176,179 shares of iShares MSCI ACWI ex US ETF worth $10.1M as of Q3 2024.
  • Raymond James & Associates bought 5,091 iShares MSCI ACWI ex US ETF shares in Q3 2024, an estimated $277K.
  • iShares MSCI ACWI ex US ETF made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1230 holding.
  • Raymond James & Associates first reported a position in iShares MSCI ACWI ex US ETF in Q2 2013 and has held it in 46 quarters since.
  • Raymond James & Associates's iShares MSCI ACWI ex US ETF position peaked at $53.3M in Q1 2018.
  • 457 funds tracked by Wall St. Rank held iShares MSCI ACWI ex US ETF as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.